Protecting Life from Chemical Abortions Act

Summary

Protecting Life from Chemical Abortions Act This bill nullifies certain changes made by the Food and Drug Administration (FDA) to dispensing requirements for mifepristone. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.) The FDA regulates the use of mifepristone through the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) program. The program requires health care providers to comply with certain requirements in order to prescribe or dispense mifepristone to end a pregnancy; the program previously included an in-person dispensing requirement that required mifepristone to be directly dispensed to patients in clinics, medical offices, or hospitals. During the COVID-19 public health emergency, the FDA temporarily stopped enforcing the in-person dispensing requirement, which allowed mail-order pharmacies to fill and dispense mifepristone prescriptions. In January 2023, the FDA modified program requirements so as to (1) remove the in-person dispensing requirement, and (2) require pharmacies to be certified in the program in order to dispense mifepristone. The modifications allow retail pharmacies, after receiving certification, to dispense mifepristone pursuant to prescriptions that are written by program-certified prescribers. The bill nullifies the January 2023 changes and prohibits the FDA from (1) exercising any enforcement discretion with respect to program requirements, or (2) reducing program protections until every state submits certain data regarding abortions to the Centers for Disease Control and Prevention. The bill also generally prohibits the declaration of a public health emergency with respect to abortions.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 17 January 2023

   Introduced

   Referred to the House Committee on Energy and Commerce.

   Source: IntroReferral

2. 17 January 2023

   Introduced

   Introduced in House

   Source: IntroReferral

3. 17 January 2023

   Introduced

   Introduced in House

   Source: IntroReferral

4. 27 January 2023

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 17 January 2023 · Download file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 17 January 2023

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 17 January 2023

  ViewDownloadOpen at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

• Introduced in House

  summary · EN · 17 January 2023

  Open at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

• Rep. Hern, Kevin [R-OK-1] · R · Sponsor
• Rep. Sessions, Pete [R-TX-17] · R · Sponsor
• Rep. Miller, Mary E. [R-IL-15] · R · Sponsor
• Rep. Duncan, Jeff [R-SC-3] · R · Sponsor
• Rep. Aderholt, Robert B. [R-AL-4] · R · Sponsor
• Rep. Ellzey, Jake [R-TX-6] · R · Sponsor
• Rep. Babin, Brian [R-TX-36] · R · Sponsor
• Rep. Grothman, Glenn [R-WI-6] · R · Sponsor
• Rep. Feenstra, Randy [R-IA-4] · R · Sponsor
• Rep. Wenstrup, Brad R. [R-OH-2] · R · Sponsor
• Rep. Loudermilk, Barry [R-GA-11] · R · Sponsor
• Rep. Guest, Michael [R-MS-3] · R · Sponsor
• Rep. Pfluger, August [R-TX-11] · R · Sponsor
• Rep. Fry, Russell [R-SC-7] · R · Sponsor
• Rep. Harshbarger, Diana [R-TN-1] · R · Sponsor
• Rep. Moolenaar, John R. [R-MI-2] · R · Sponsor
• Rep. Rose, John W. [R-TN-6] · R · Sponsor
• Rep. Jackson, Ronny [R-TX-13] · R · Sponsor
• Rep. Cline, Ben [R-VA-6] · R · Sponsor
• Rep. Mast, Brian J. [R-FL-21] · R · Sponsor
• Rep. Finstad, Brad [R-MN-1] · R · Sponsor
• Rep. Boebert, Lauren [R-CO-4] · R · Sponsor
• Rep. Green, Mark E. [R-TN-7] · R · Sponsor
• Rep. Lamborn, Doug [R-CO-5] · R · Sponsor
• Rep. Baird, James R. [R-IN-4] · R · Sponsor
• Rep. Hinson, Ashley [R-IA-2] · R · Sponsor
• Rep. LaMalfa, Doug [R-CA-1] · R · Sponsor
• Rep. Clyde, Andrew S. [R-GA-9] · R · Sponsor
• Rep. Weber, Randy K. Sr. [R-TX-14] · R · Sponsor
• Sen. Banks, Jim [R-IN] · R · Sponsor
• Rep. Webster, Daniel [R-FL-11] · R · Sponsor
• Rep. Langworthy, Nicholas A. [R-NY-23] · R · Sponsor
• Rep. Kelly, Trent [R-MS-1] · R · Sponsor
• Rep. Rutherford, John H. [R-FL-5] · R · Sponsor
• Rep. Gosar, Paul A. [R-AZ-9] · R · Sponsor
• Rep. Good, Bob [R-VA-5] · R · Cosponsor
• Rep. Bost, Mike [R-IL-12] · R · Cosponsor
• Rep. Yakym, Rudy [R-IN-2] · R · Cosponsor
• Rep. Self, Keith [R-TX-3] · R · Cosponsor
• Rep. Crenshaw, Dan [R-TX-2] · R · Cosponsor
• Rep. Newhouse, Dan [R-WA-4] · R · Cosponsor
• · hsif00 · Standing

Related records

No cross-record relationships stored yet.